Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account
HL select global growth shares

Managers' blog

AccumulationIncome ?

Sell: 127.81p|Buy: 127.81p|Change -0.11p (-0.09%)

Correct as at 18/09/2020

Sell: 127.47p|Buy: 127.47p|Change -0.11p (-0.09%)

Correct as at 18/09/2020

Important information - The value of this fund can fall as well as rise so you could get back less than you invest. This information isn’t personal advice. If you're not sure whether an investment is suitable for your circumstances please contact us for personal advice. The HL Select Global Growth Shares fund is managed by our sister company HL Fund Managers Ltd.

Important portfolio changes, regular manager insight and monthly roundups

HL SELECT GLOBAL GROWTH SHARES

HL Select Global Growth shares Q2 2020 review

Unsurprisingly, during the second quarter the impact of coronavirus continued to be the most significant factor influencing equity markets. Read more

Managers' thoughts

HL SELECT GLOBAL GROWTH SHARES

New Holding - Zebra Technologies

Zebra provides a wide range of products that help retailers, logistics and healthcare providers identify and track their inventory. Read more

Fund changes

HL SELECT GLOBAL GROWTH SHARES

New Holdings - Vulcan and Texas Pacific Land Trust

We’ve added a couple of businesses to the fund, using the fall in recent prices as an opportunity to own high quality businesses with unchanged long term growth opportunities. Read more

Fund changes

HL SELECT GLOBAL GROWTH SHARES

New Holdings - IDEXX Laboratories and Cryoport

Over the last few months we have added two new healthcare businesses to the portfolio, IDEXX Laboratories and Cryoport. Read more

Fund changes

HL SELECT UK GROWTH SHARES
HL SELECT UK INCOME SHARES
HL SELECT GLOBAL GROWTH SHARES

What Does Quality Look Like?

Investing in the stock market is a fundamentally risky business. Wars, pandemics, recessions and straightforward corporate mistakes can all damage or destroy an investment’s value. Even the best-managed businesses can face challenges that hold them back. Read more

Managers' thoughts

HL SELECT UK GROWTH SHARES
HL SELECT UK INCOME SHARES
HL SELECT GLOBAL GROWTH SHARES

Where are we now? The HL Select fund managers’ view of the world

The Covid-19 virus has proven more influential than any other health crisis in our lifetimes. Vast swathes of industry have been shut down in the efforts to contain the virus and economies are only now starting to reopen. Read more

Managers' thoughts

HL SELECT GLOBAL GROWTH SHARES

HL Select Global Growth 1 Year Review

An eventful first year for HL Select Global Growth Shares has seen escalations of the US and China trade war, a UK general election and we are now managing through a global pandemic. Read more

Managers' thoughts

HL SELECT GLOBAL GROWTH SHARES

2020 first quarter review

The ‘HL Select’ way is to invest in high quality businesses that we believe can prosper over the long-run. But this doesn’t mean their share prices won’t be affected in the short-term. Read more

Managers' thoughts

HL SELECT GLOBAL GROWTH SHARES

New Holding - Pernod Ricard

Pernod Ricard is the second largest spirits manufacturer in the world. Find out why we decided to add this share to the fund. Read more

Fund changes

HL SELECT GLOBAL GROWTH SHARES

2019 fourth quarter review

Gareth Campbell reviews the fourth quarter of 2019, what happened and what changes were made. Read more

Managers' thoughts

More
More
Loading

Important information - These articles are not advice or a recommendation to buy, sell or hold any investment. No view is given on the present or future value or price of any investment, and investors should form their own view on any proposed investment. These articles have not been prepared in accordance with legal requirements designed to promote the independence of investment research and is considered a marketing communication. Non-independent research is not subject to FCA rules prohibiting dealing ahead of research, however HL has put controls in place (including dealing restrictions, physical and information barriers) to manage potential conflicts of interest presented by such dealing. Please see our full non-independent research for more information.